arrow
H

Hans-Ulrich Schildhaus

Université de Lille
H指数:47
被引数:9,366

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

How Should Primary Pulmonary Sarcoma be Staged? Results of an International Multicentre Analysis

如何对原发性肺肉瘤进行分期?一项国际多中心分析的结果

2026-02-010
PRE
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study

原发性肺肉瘤根治性治疗患者的结局:一项国际多中心回顾性研究的结果

2025-12-011
OAAI
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP®)

德国病理学质量保证倡议(QuIP®)首次叶酸受体α检测试验的结果

2025-11-190
OAAI
A Global Ring Study: Concordance Between Ventana PATHWAY anti-HER2/neu (4B5) Companion Diagnostic Assay and Comparators in Detecting HER2-low Breast Cancer

全球环研究:Ventana PATHWAY anti-HER2/neu (4B5) 伴随诊断检测试剂盒与比较检测HER2低表达乳腺癌的一致性研究

2025-08-090
OAAI
Report of a national external quality assessment program for HER2-low expression in breast cancer—options for increased accuracy with standardized methodology

HER2低表达乳腺癌国家外部质量评估计划报告——标准化方法提高准确性的方案

2025-08-050
OA
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival
2025-01-170
OAAI
High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial

PTEN免疫组织化学的高观察者间变异性定义了低至中危前列腺癌的PTEN状态: 首次德国ring试验的结果

2024-12-090
OAAI
Assessment of the physiological effects and safety of transpulmonary chemoembolization with doxorubicin on pulmonary tissue using a human-isolated lung perfusion model

基于人源离体肺灌注模型对多柔比星经肺化疗栓塞术在肺组织中的生理效应及安全性评估

2024-12-050
OAAI
THE ROLE OF FIBROBLAST ACTIVATION PROTEIN IN GLIOBLASTOMA AND GLIOSARCOMA - A COMPARISON OF TISSUE, 68GA-FAPI-46 POSITRON EMISSION TOMOGRAPHY AND SURVIVAL DATA
2024-11-110
PRE
THE ROLE OF FIBROBLAST ACTIVATION PROTEIN IN GLIOBLASTOMA AND GLIOSARCOMA - A COMPARISON OF TISSUE, 68GA-FAPI-46 POSITRON EMISSION TOMOGRAPHY AND SURVIVAL DATA
2024-10-170
PRE
Primary pulmonary sarcoma: A EURACAN project

原发性肺肉瘤:一项EURACAN项目

2024-09-010
PRE
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity
2024-08-012
OAAI
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68 Ga-FAPI-46 PET Data, and Survival Data
2024-07-030
PRE
Homologous recombination repair (HRR) deficiency in biliary tract cancers: Clinical implications in subsequent therapy lines and correlation with platinum sensitivity
2024-06-010
PRE
Concordance between the DESTINY-Breast04 clinical trial assay (4B5[CDx]) and other HER2 IHC assays for HER2-low breast cancer in real-world practice: First phase of a large-scale, multicenter global ring study
2024-03-220
PRE
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies

未知原发癌的综合生物标志物诊断,以确定符合精确医疗治疗条件的患者

2024-03-012
OA
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor

成纤维细胞活化蛋白 α 定向显像与孤立性纤维瘤的治疗

2024-01-043
OA